AlphaMaven AlphaMaven

Medical Angels scrubs up Michael Batko as venture partner to raise $40 million fund

Reported by Startupdaily
Jul 1, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Medical Angels appoints Michael Batko, former Startmate CEO, as venture partner to lead fundraising efforts for a $40 million dedicated venture fund.
  • • Batko brings substantial track record: 8+ years backing 300+ startups with top 5% returns, previously helmed Startmate into Australia's most active seed investor with $50M+ raised and 228 first-cheque investments.
  • • The $40 million fund represents a significant expansion of Batko's investing vehicle, building on his angel syndicate (Allied Venture Partners, launched Q4 2020) and prior ~$4 million semi-annual funds that delivered up to 8.9x cash-on-cash returns.
  • • Appointment signals Medical Angels' strategy to deepen venture capital deployment in healthcare/medtech sector through an experienced operator with demonstrated deal sourcing and portfolio construction capabilities.
Summary
Medical Angels has recruited Michael Batko as venture partner to lead a new $40 million fund, according to Startup Daily. Batko's appointment underscores the investor group's intent to scale healthcare-focused venture investing through an operator with proven track record in early-stage capital deployment and founder support.

Batko's background establishes credibility for the role. As former CEO of Startmate, Australia's oldest and largest startup accelerator, he oversaw the development of a portfolio exceeding 300 alumni companies valued collectively at $4.5 billion. During his tenure at Startmate, he raised $50 million-plus and provided first-cheque capital to 228 companies, positioning Startmate as Australia's most active seed investor before his 2025 exit. His personal investment track record spans 8+ years of venture backing with top 5% returns.

Prior to the Medical Angels appointment, Batko had been exploring a dedicated fund vehicle independent of Startmate operations. In Q4 2020, he launched Allied Venture Partners, an angel syndicate enabling co-investment alongside his deal flow. His historical fund-raising cadence involved launching approximately $4 million vehicles every six months, with those funds achieving returns as high as 8.9x cash-on-cash. This performance provides a foundation for managing a significantly larger $40 million vehicle.

The $40 million fund size represents a substantial scaling of Batko's investment activity, suggesting Medical Angels has committed substantial capital to the healthcare/medtech thesis under his stewardship. The appointment leverages both his sourcing relationships within the Australian startup ecosystem and his operational experience scaling early-stage portfolio companies, two capabilities historically critical to seed-to-Series A fund success.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Startupdaily Medical Angels scrubs up Michael Batko as venture partner to raise $40 million fund